Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01681810 · ClinicalTrials.gov registry record · Phase 2
Oral Nitrite in Adults With Metabolic Syndrome and Hypertension
A Phase 2 study, sponsored by Gladwin, Mark, MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT01681810 is a Phase 2 study that has completed, run by Gladwin, Mark, MD. The registered enrollment target is 20 participants.
The verdict
NCT01681810, a Phase 2 study, has completed, sponsored by Gladwin, Mark, MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This research study is being conducted to examine the effects of daily inorganic nitrite treatment on the cardiometabolic and hormonal disturbances observed in overweight/obese adults with the metabolic syndrome and high blood pressure. Ultimately, oral nitrite therapy may have a major impact on the prevention and treatment of both diabetes and cardiovascular disease.
Interventions
- DRUG 14Nitrogen Sodium Nitrite
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-10 |
| Est. Completion | 2018-03-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01681810
The ClinicalTrials.gov registry entry for NCT01681810 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gladwin, Mark, MD, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 14Nitrogen Sodium Nitrite is the first listed.
NCT01681810 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01681810 about?
NCT01681810 is a clinical study titled "Oral Nitrite in Adults With Metabolic Syndrome and Hypertension". This research study is being conducted to examine the effects of daily inorganic nitrite treatment on the cardiometabolic and hormonal disturbances observed in overweight/obese adults with the metabolic syndrome and high blood pressure. Ultimately, oral nitrite therapy may have a major impact on the...
What is the current status of trial NCT01681810?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2012-10. Estimated completion is 2018-03-08.
What interventions are being tested in trial NCT01681810?
The interventions under investigation include: 14Nitrogen Sodium Nitrite (DRUG).
Who is sponsoring clinical trial NCT01681810?
This trial is sponsored by Gladwin, Mark, MD, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.